drugset / Trial / NCT03156153
A Study of Bumetanide for the Treatment of Autism Spectrum Disorders
Phase 2
Completed
120 enrolled
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai Jiao Tong University School of Medicine · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The investigators are going to carry out a randomized double-blind placebo-controlled trial to study the efficiency and mechanism of bumetanide on the treatment of children with Autism Spectrum Disorder.
Timeline
- Start
- 2017-05-24
- Primary completion
- 2019-07-08
- Completion
- 2019-07-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bumetanide | Small molecule | 0.5 mg | Oral |